Log in

NYSEAMERICAN:MYOMyomo Stock Price, Forecast & News

$3.94
+0.28 (+7.65 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.77
Now: $3.94
$4.70
50-Day Range N/A
52-Week Range
$2.82
Now: $3.94
$40.00
Volume3.93 million shs
Average Volume532,324 shs
Market Capitalization$11.09 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Read More
Myomo logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MYO
CUSIPN/A
Phone+1-617-9969058

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees45
Market Cap$11.09 million
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable

Receive MYO News and Ratings via Email

Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter.

Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Myomo?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Myomo.

When is Myomo's next earnings date?

Myomo is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Myomo.

How were Myomo's earnings last quarter?

Myomo Inc (NYSEAMERICAN:MYO) released its quarterly earnings results on Thursday, May, 14th. The company reported ($2.51) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($2.06) by $0.45. The company earned $1.01 million during the quarter, compared to the consensus estimate of $0.78 million. View Myomo's earnings history.

What guidance has Myomo issued on next quarter's earnings?

Myomo updated its second quarter 2020 Pre-Market earnings guidance on Monday, June, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600K - 700K, compared to the consensus revenue estimate of $370K.

What price target have analysts set for MYO?

3 Wall Street analysts have issued twelve-month price objectives for Myomo's stock. Their forecasts range from $2.00 to $15.00. On average, they expect Myomo's share price to reach $8.50 in the next year. This suggests a possible upside of 115.7% from the stock's current price. View analysts' price targets for Myomo.

Has Myomo been receiving favorable news coverage?

Media headlines about MYO stock have trended negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Myomo earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Myomo.

Are investors shorting Myomo?

Myomo saw a decrease in short interest in June. As of June 30th, there was short interest totaling 73,600 shares, a decrease of 22.3% from the June 15th total of 94,700 shares. Based on an average daily trading volume, of 343,400 shares, the short-interest ratio is currently 0.2 days. Currently, 2.7% of the shares of the stock are sold short. View Myomo's Current Options Chain.

Who are some of Myomo's key competitors?

What other stocks do shareholders of Myomo own?

Who are Myomo's key executives?

Myomo's management team includes the following people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 64)
  • Mr. Jonathan Naft, VP & GM (Age 54)
  • Mr. David A. Henry, Chief Financial Officer (Age 58)
  • Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 69)
  • Dr. Brandon Green DO, BOCP, Chief Medical Officer (Age 72)

What is Myomo's stock symbol?

Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO."

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $3.94.

How big of a company is Myomo?

Myomo has a market capitalization of $11.09 million. Myomo employs 45 workers across the globe.

What is Myomo's official website?

The official website for Myomo is myomo.com.

How can I contact Myomo?

Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.